FDA Cracks Down on Opioid-Like Kratom Ingredient in Viral Drinks

In a significant move, the Food and Drug Administration (FDA) has announced plans to crack down on products containing 7-Hydroxymitragynine (7-OH), a chemical byproduct derived from the kratom plant. This announcement comes in the wake of a viral TikTok video that sparked renewed attention on the risks associated with kratom-based drinks.

The FDA's focus is specifically on 7-OH, which has been found to have opioid-like effects, rather than kratom as a whole. During a press conference on July 29, 2025, FDA Commissioner Martin Makary stated the organization's intention to initiate the process of scheduling 7-OH as an illicit substance, pending approval from the Drug Enforcement Administration.

This development is particularly relevant for Michigan, where kratom products, including those with high concentrations of 7-OH, are currently sold across the state with no statewide regulations in place. Health experts have warned that the ability to easily access these potentially addictive substances, often in the form of drinks, capsules, and powders, has made them more susceptible to abuse.

The increased scrutiny on kratom and its derivatives comes after a recent class-action lawsuit against a company that allegedly marketed its kratom tonic as a healthy alternative to alcohol. The company has since added warnings about the habit-forming and harmful nature of its products if consumed irresponsibly, as well as a 21-and-over restriction.

As the FDA and other authorities continue to address the growing concerns surrounding kratom and its potent derivatives, the future of these products in Michigan remains uncertain. Consumers and policymakers alike will be closely watching the developments in the coming months.